Mirati Therapeutics Inc

We track 2 ClinicalTrials.gov studies led by Mirati Therapeutics Inc. The portfolio skews toward Phase 2 (1 trials).

2 clinical trials sponsored by Mirati Therapeutics Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 3 1
50%

Trial Status Breakdown

Trials by Mirati Therapeutics Inc

Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)

NCT07415031 · NOT YET RECRUITING · Phase 2

A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT06875310 · RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Mirati Therapeutics Inc sponsor?

Mirati Therapeutics Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 3.

What conditions does Mirati Therapeutics Inc research?

Mirati Therapeutics Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Mirati Therapeutics Inc recruiting for clinical trials?

Yes, Mirati Therapeutics Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More